October 15, 2024
U.S. Department of Defense awarded $2.8 million to UNC Institute for Trauma Recovery researchers led by Samuel McLean, MD, to test the safety and efficacy of BXCL501 – sublingual dexmedetomidine created by BioXcel Therapautics for treating acute stress reaction symptoms and preventing posttraumatic stress.
October 2, 2024
UNC Center for Excellence in Community Mental Health unveils the Farm at Penny Lane Food Shuttle, made possible with $100,000 in funding from UnitedHealthcare.
September 17, 2024
The National Institutes of Mental Health awarded a $2.5-million grant to UNC School of Medicine researchers Adam Bryant Miller, PhD, and Andrea Pelletier-Baldelli, PhD, in the UNC Department of Psychiatry, to study the alarming rise of suicidal behavior in young girls.
August 26, 2024
In a small pilot study, UNC School of Medicine researchers led by Flavio Frohlich, PhD, used a new closed-loop system to measure the electrical brain patterns of individual patients and then stimulate those patterns with a weak electrical current, resulting in significantly improved symptoms of major depressive disorder.
August 2, 2024
A new review article written by Patrick Sullivan, MD, FRANZCP, the Yeargan Distinguished Professor of Psychiatry and Genetics, outlines the genetic foundations for schizophrenia.
June 25, 2024
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.
June 19, 2024
Headspace, the popular wellness app, is available to UNC Health Employees, a partnership highlighted in a two-part episode of the TarHeal Wellness podcast exploring the partnership and available resources, including evidence-based meditation and mindfulness tools, mental health coaching, therapy, psychiatry, and family support.
May 13, 2024
The UNC School of Medicine lab of Zoe McElligott, PhD, and colleagues found that the animal tranquilizer xylazine activates opioid receptors in the brain, suggesting a reason why the treatment naloxone triggers a more severe withdrawal response when given to individuals on fentanyl/xylazine and suffering from respiratory depression.
April 24, 2024
UNC Addiction Medicine Program and CORE NC presented on "Low Threshold MOUD: Partnering with Community to Expand Access" during the Morning Plenary at the 2024 Addiction Medicine Conference and shared new video on the Atlas Mobile Clinic community-campus partnership in Robeson County.
April 4, 2024
One of the main priorities of the Mental Health Equity and Inclusion Program is to enlarge the number of qualified students interested in pursuing careers in psychiatry. As an intentional effort to accomplish this goal, the program engaged with medical students at a national conference interested in learning more about residency training at UNC, future career options in psychiatry, the Triangle as a place to live, and how they may become more engaged in the pursuit of mental health equity.
January 29, 2024
Becker’s Hospital Review talks with Nadia Charguia, MD, associate professor in the Department of Psychiatry, about physician burnout, struggles, well-being, and efforts in reducing departure.
December 19, 2023
Dea Garic, PhD, and Mark Shen, PhD, both in the UNC School of Medicine’s Department of Psychiatry, have found that enlarged perivascular spaces in the brains of babies, caused by an accumulation of excess cerebrospinal fluid, have a 2.2 times greater chance of developing autism later in life.